Indian J Med Microbiol Close
 

Table 1: Summary of on-going clinical trials evaluating polyadenosine diphosphate-ribose polymerase inhibitors as monotherapy or in combination with other therapeutic agents in metastatic castrate-resistant prostate cancer

Table 1: Summary of on-going clinical trials evaluating polyadenosine diphosphate-ribose polymerase inhibitors as monotherapy or in combination with other therapeutic agents in metastatic castrate-resistant prostate cancer